spinoffs
A spinoff takes place when a company decides to get rid of a portion of its asset base, possibly because it wants to focus its activities elsewhere, but is unable to sell the assets for a price that it feels reflects their value. Instead, the parent company sets the assets up as a separate company, then hands out shares in that publicly listed firm to its current investors.
Read More
Close
We first recommended specialty insurer Trisura in the third issue (December 2017) of TSI Spinoffs & Takeovers. It has not disappointed us.
Trisura took its current form on June 22, 2017, when Brookfield Asset Management Inc. (Toronto symbol BAM.A) spun it off as a separate company....
Trisura took its current form on June 22, 2017, when Brookfield Asset Management Inc. (Toronto symbol BAM.A) spun it off as a separate company....
Investing in the best TSX stocks can help you maximize your returns. Learn here about what we look for when making top picks from the Toronto Stock Exchange
Spinoff activity continues to accelerate as the stock market moves on from its COVID-19 shock last year. We continue to see spinoffs as full of opportunity, but for now prefer the three parent firms below to their spinoffs.
MERCK & CO. INC., $77 is a spinoff buy....
MERCK & CO. INC., $77 is a spinoff buy....
Swiss pharmaceutical giant Novartis spun off Alcon just last year. And as we’ve said many times before, spinoffs are the closest thing you can find to a sure thing, regardless of the market’s ups and downs.
The stock is already up over 80% from its March 2020 lows, but we think it can go much higher....
The stock is already up over 80% from its March 2020 lows, but we think it can go much higher....
We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc.
Over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie has further gains ahead for investors....
Over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie has further gains ahead for investors....
Corteva shares offer investors a number of pluses: Not only is the company at the forefront of key agricultural trends, a prominent activist is driving it to make improvements. As well, the stock is a spinoff. Over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing....
DANAHER CORP. $244 is a buy. The company (New York symbol DHR; Manufacturing sector; Shares o/s 713.1 million; Market cap: $174.0 billion; Dividend yield: 0.4%; Takeover Target Rating: Medium; www.danaher.com) is a leading maker of precision-testing equipment and tools....
The breakup of multinational chemical maker DowDuPont into three separate firms—Dupont de Nemours, Dow, and Corteva—is a great example of how spinoffs can unlock hidden value for investors.
Looking at the two new firms, Dow has gained roughly 30% while Corteva has jumped 60%....
The stock market rebound from the March 2020 downturn at the start of the pandemic spurred several spinoff announcements. More announcements have followed in the year since. Here are two recent spinoffs (one completed, one upcoming) that we like.
VERINT SYSTEMS INC....
BCE may have disappointed some aggressive investors in the past five years—it’s now roughly in the middle of its $50 to $65 price range for that period. However, income-seekers are no doubt pleased at the rise in its dividend, from $2.60 a share in 2015 to the current 2021 rate of $3.50, in the midst of an historic depression in bond interest rates and other sources that investors rely on for income.
While BCE’s payout has climbed, the company and its industry have made fundamental progress that’s likely to pay off with substantial gains in the next five years.
We’re used to—and quite happy with—the variable performance we’ve received over the years from BCE....
While BCE’s payout has climbed, the company and its industry have made fundamental progress that’s likely to pay off with substantial gains in the next five years.
We’re used to—and quite happy with—the variable performance we’ve received over the years from BCE....